CES Limited is an Information Technology (IT) and Information Technology Enabled Services (ITES) provider, dedicated to serving the midsize market of global enterprises. It has mainly two divisions i.e., IT Division and ITES Division. The Company is listed on BSE Limited and has only 26 shareholders.
The Transaction:
Management of CES Limited (Demerged Company) proposed the demerger of the "ITES Business" into its presently "wholly owned subsidiary" i.e., CES Technology Private Limited (Resulting Company) on going concern basis through scheme of arrangement.
Appointed Date fixed for this transaction is 1st April 2022 and the scheme will become effective from the date of filing certified copy of the scheme with the Registrar of Companies.
Shareholding Pattern of CES Limited:
Shares of CES Limited are not frequently traded. Out of 14 shareholders, few shareholders might not be traceable since they are still holding the shares in physical form.
ITES Division getting demerged has Total Assets of Rs.45.50 Crores consist of majorly Investments in the subsidiary companies in India, USA and Trade Receivables.
Since the investment in the foreign subsidiaries is getting transferred, post scheme of arrangement, Resulting Company will have to comply with the FEMA Compliances w.rt Overseas Direct Investment.
Scheme of Arrangement also providing for the following:
1. Delisting of the Demerged Company from stock exchange.
2. Reorganization of capital of Demerged and Resulting Company
Rationale of the Scheme:
هذه القصة مأخوذة من طبعة September 2022 من M & A Critique.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة September 2022 من M & A Critique.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Raymond Group continues Segregation of its Business Verticals
After successful demerger of \"Lifestyle Business,\" Raymond Limited announced yet another restructuring to unlock further value for stakeholders.
Ultratech Cements adds India Cement in its shopping cart
India's Cement Industry is poised for consolidation. In recent past we have seen multiple large & small acquisitions in cement segment for consolidating positions.
Valor Estate Limited: "Diversification" to "Sepration" of Hospitality Business
“From investments in hospitality business, the demerger transaction will enable VEL to start its construction in hospitality”
SIEMENS Energy to be a separate entity in alignment with global strategy
Siemens AG announced its Vision 2020+ which included the spin-off of its Gas & Power [G&P) i.e., Energy Business into Siemens Energy.
Arvind Group separates its Advanced Material Business for independent growth trajectory
Advanced Material Business (AMD) of Arvind Limited focuses on advanced materials and caters to customer needs across the textile value chain, including specialty yarns, fabrics, and ready-made products.
Merger for bail-out from debt obligation
Ind Swift Limited (herein after also referred to as 'ISL' or 'Transferor Company') is engaged in the business of manufacturing of Pharmaceutical Products.
Batliboi Ltd. merging its associate company
Batliboi Limited has a history of collaborations with various foreign technical partners and has subsidiaries like Hydraulic & General Engineers Ltd. and Batliboi International Ltd. In March 2024, the board of Directors of Batliboi Limited accorded their approval for the merger of promoter owned private company with itself.
TVS Motors issuances of convertible preference shares as bonus instead of dividend
Recently, well known auto manufacturer announced the issuance of preference shares as a bonus to all equity shareholders.
Aditya Birla Fashion & Retails Scheme to undo its consolidation
Corporate restructuring saga continues for Aditya Birla Group.
Advent International to combine its listed & private entity business
Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company.
